345 related articles for article (PubMed ID: 28866808)
1. Chylomicrons stimulate incretin secretion in mouse and human cells.
Psichas A; Larraufie PF; Goldspink DA; Gribble FM; Reimann F
Diabetologia; 2017 Dec; 60(12):2475-2485. PubMed ID: 28866808
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypeptide from intestinal K cells in rodents.
Moss CE; Marsh WJ; Parker HE; Ogunnowo-Bada E; Riches CH; Habib AM; Evans ML; Gribble FM; Reimann F
Diabetologia; 2012 Nov; 55(11):3094-103. PubMed ID: 22872212
[TBL] [Abstract][Full Text] [Related]
3. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.
Mayer F; Gunawan AL; Tso P; Aponte GW
Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G23-G35. PubMed ID: 32421358
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms underlying glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion.
Reimann F; Gribble FM
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):13-9. PubMed ID: 27186350
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of proglucagon gene expression by human GPR119 in enteroendocrine L-cell line GLUTag.
Chepurny OG; Bertinetti D; Diskar M; Leech CA; Afshari P; Tsalkova T; Cheng X; Schwede F; Genieser HG; Herberg FW; Holz GG
Mol Endocrinol; 2013 Aug; 27(8):1267-82. PubMed ID: 23798572
[TBL] [Abstract][Full Text] [Related]
7. GPR119, a Major Enteroendocrine Sensor of Dietary Triglyceride Metabolites Coacting in Synergy With FFA1 (GPR40).
Ekberg JH; Hauge M; Kristensen LV; Madsen AN; Engelstoft MS; Husted AS; Sichlau R; Egerod KL; Timshel P; Kowalski TJ; Gribble FM; Reiman F; Hansen HS; Howard AD; Holst B; Schwartz TW
Endocrinology; 2016 Dec; 157(12):4561-4569. PubMed ID: 27779915
[TBL] [Abstract][Full Text] [Related]
8. βHB inhibits glucose-induced GLP-1 secretion in GLUTag and human jejunal enteroids.
Elebring E; Casselbrant A; Persson SMT; Fändriks L; Wallenius V
J Mol Endocrinol; 2023 May; 70(4):. PubMed ID: 36810364
[TBL] [Abstract][Full Text] [Related]
9. Chylomicron formation and secretion is required for lipid-stimulated release of incretins GLP-1 and GIP.
Lu WJ; Yang Q; Yang L; Lee D; D'Alessio D; Tso P
Lipids; 2012 Jun; 47(6):571-80. PubMed ID: 22297815
[TBL] [Abstract][Full Text] [Related]
10. Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways.
Lan H; Lin HV; Wang CF; Wright MJ; Xu S; Kang L; Juhl K; Hedrick JA; Kowalski TJ
Br J Pharmacol; 2012 Apr; 165(8):2799-807. PubMed ID: 22029751
[TBL] [Abstract][Full Text] [Related]
11. Intestinal CART is a regulator of GIP and GLP-1 secretion and expression.
Shcherbina L; Lindqvist A; Thorén Fischer AH; Ahlqvist E; Zhang E; Falkmer SE; Renström E; Koffert J; Honka H; Wierup N
Mol Cell Endocrinol; 2018 Nov; 476():8-16. PubMed ID: 29627317
[TBL] [Abstract][Full Text] [Related]
12. ID1-Mediated BMP Signaling Pathway Potentiates Glucagon-Like Peptide-1 Secretion in Response to Nutrient Replenishment.
Jeong JW; Kim M; Lee J; Lee HK; Ko Y; Kim H; Fang S
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481541
[TBL] [Abstract][Full Text] [Related]
13. Lipid derivatives activate GPR119 and trigger GLP-1 secretion in primary murine L-cells.
Hodge D; Glass LL; Diakogiannaki E; Pais R; Lenaghan C; Smith DM; Wedin M; Bohlooly-Y M; Gribble FM; Reimann F
Peptides; 2016 Mar; 77():16-20. PubMed ID: 26144594
[TBL] [Abstract][Full Text] [Related]
14. Novel extrapancreatic effects of incretin.
Yamada Y; Tsukiyama K; Sato T; Shimizu T; Fujita H; Narita T
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):76-9. PubMed ID: 27186360
[TBL] [Abstract][Full Text] [Related]
15. Activation of enteroendocrine membrane progesterone receptors promotes incretin secretion and improves glucose tolerance in mice.
Flock GB; Cao X; Maziarz M; Drucker DJ
Diabetes; 2013 Jan; 62(1):283-90. PubMed ID: 22933106
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Gpr17 deficiency improves glucose metabolism by promoting GLP-1 secretion.
Yan S; Conley JM; Reilly AM; Stull ND; Abhyankar SD; Ericsson AC; Kono T; Molosh AI; Kubal CA; Evans-Molina C; Ren H
Cell Rep; 2022 Jan; 38(1):110179. PubMed ID: 34986353
[TBL] [Abstract][Full Text] [Related]
17. Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1.
Xiong Y; Swaminath G; Cao Q; Yang L; Guo Q; Salomonis H; Lu J; Houze JB; Dransfield PJ; Wang Y; Liu JJ; Wong S; Schwandner R; Steger F; Baribault H; Liu L; Coberly S; Miao L; Zhang J; Lin DC; Schwarz M
Mol Cell Endocrinol; 2013 Apr; 369(1-2):119-29. PubMed ID: 23403053
[TBL] [Abstract][Full Text] [Related]
18. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion.
Edfalk S; Steneberg P; Edlund H
Diabetes; 2008 Sep; 57(9):2280-7. PubMed ID: 18519800
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of incretin secretion by dietary lipid: is it dose dependent?
Yoder SM; Yang Q; Kindel TL; Tso P
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G299-305. PubMed ID: 19520739
[TBL] [Abstract][Full Text] [Related]
20. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
Hira T; Koga T; Sasaki K; Hara H
Biochem Biophys Res Commun; 2017 Oct; 492(2):161-165. PubMed ID: 28803984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
